|
|
Uta C. Hoppe, Eduardo Marbán, David C. Johns
J Clin Invest. 2000;
105(8):1077
doi:10.1172/JCI8757
Abstract |
Full text
| PDF

H
eart failure leads to marked suppression of the Ca2+-independent transient outward current (Ito1), but it is not clear whether Ito1 downregulation suffices to explain the concomitant action potential prolongation. To investigate the role of Ito1 in cardiac repolarization while circumventing culture-related action potential alterations, we injected adenovirus vectors in vivo to overexpress or to suppress Ito1 in guinea pigs and rats, respectively. Myocytes were isolated 72 hours after intramyocardial injection and stimulation of the ecdysone-inducible vectors with intraperitoneal injection of an ecdysone analog. Kv4.3-infected guinea pig myocytes exhibited robust transient outward currents. Increasing density of Ito1 progressively depressed the plateau potential in Kv4.3-infected guinea pig myocytes and abbreviated action potential duration (APD). In vivo infection with a dominant-negative Kv4.3-W362F construct suppressed peak Ito1 in rat ventriculocytes, elevated the plateau height, significantly prolonged the APD, and resulted in a prolongation by about 30% of the QT interval in surface electrocardiogram recordings. These results indicate that Ito1 plays a crucial role in setting the plateau potential and overall APD, supporting a causative role for suppression of this current in the electrophysiological alterations of heart failure. The electrocardiographic findings indicate that somatic gene transfer can be used to create gene-specific animal models of the long QT syndrome.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(11)
| Title and authors |
Publication |
Year |
Analysis of the contribution of Ito to repolarization in canine ventricular myocardium
L Virág, N Jost, R Papp, I Koncz, A Kristóf, Z Kohajda, G Harmati, B Carbonell-Pascual, JM Ferrero Jr, JG Papp, PP Nánási, A Varró
|
British Journal of Pharmacology
|
2011 |
Distinct regulation of cardiac If current via thyroid receptors alpha1 and beta1
Natig Gassanov, Fikret Er, Jeannette Endres-Becker, Martin Wolny, Christoph Schramm, Uta C. Hoppe
|
Pflugers Arch - Eur J Physiol
|
2009 |
Impact of testosterone on cardiac L-type calcium channels and Ca2+ sparks: Acute actions antagonize chronic effects
Fikret Er, Guido Michels, Mathias C. Brandt, Ismail Khan, Hannelore Haase, Michael Eicks, Michael Lindner, Uta C. Hoppe
|
Cell Calcium
|
2007 |
Gender Differences in Brugada Syndrome
LARS ECKARDT
|
Journal of Cardiovascular Electrophysiology
|
2007 |
From Gene Therapy and Stem Cells to Clinical Electrophysiology
LIOR YANKELSON, LIOR GEPSTEIN
|
Pacing and Clinical Electrophysiology
|
2006 |
Mutations in the genes KCND2 and KCND3 encoding the ion channels Kv4.2 and Kv4.3, conducting the cardiac fast transient outward current (ITO,f), are not a frequent cause of long QT syndrome
Rune Frank-Hansen, Lars Allan Larsen, Paal Andersen, Cathrine Jespersgaard, Michael Christiansen
|
Clinica Chimica Acta
|
2005 |
When the DREAM is gone:from basic science to future prospectives in pain management and beyond
Hai-Ying M Cheng, Josef M Penninger
|
Expert Opin. Ther. Targets
|
2003 |
Structural and Functional Basis for the Long QT Syndrome: Relevance to Veterinary Patients
Melissa R. Finley, James D. Lillich, Robert F. Gilmour Jr, Lisa C. Freeman
|
Journal of Veterinary Internal Medicine
|
2003 |
Dual gene therapy with SERCA1 and Kir2.1 abbreviates excitation without suppressing contractility
Irene L. Ennis, Ronald A. Li, Anne M. Murphy, Eduardo Marbán, H. Bradley Nuss
|
J. Clin. Invest.
|
2002 |
Ecdysone-controlled expression of transgenes
Lloyd D Graham
|
Expert Opin. Biol. Ther.
|
2002 |
|